[ACT]IVATED AML - Patient Empowerment Network

[ACT]IVATED AML

May 2024

An [ACT]IVATED patient is informed, empowered, and engaged in their care. Take advantage of health literacy tools and plug into resources that keep you in the know for the latest in acute myeloid leukemias. Stay [ACT]IVATED.

Program topics includes:

Advances in AML Treatment and Research
AML Clinical Trials, Access, and Health Disparities
Bone Marrow Biopsies & Predictors of AML Outcomes
Patient-Centered Care & Treatment Decisions
[ACT]IVATED AML Resources
AML Patient Self-Advocacy Profiles

Personalize Your Experience!

Create an account to save items and receive information curated just for you.

Advances in AML Treatment and Research

What Are Potential Impacts of Artificial Intelligence on AML Patient Care?

May 24, 2024

Advancements in AML Treatment | Tailoring Therapies to Individual Patients

March 24, 2024

What AML Mutations Are Associated With Adverse Outcomes?

February 1, 2023

Challenges in Treating TP53-Mutated AML, Hope on the Horizon

February 1, 2023

A Look at Ongoing Acute Myeloid Leukemia Phase III Trials

February 1, 2023

What Does Triplet Therapy in AML Mean for the Future?

February 1, 2023

A Look at Lower Intensity Chemotherapy in Untreated AML

February 1, 2023

A Look at Treatment Strategies for High-Risk AML Patients

February 1, 2023

Why Is the Menin Pathway Important in AML?

February 1, 2023

The Importance of the FLT3 Mutation in AML

February 1, 2023

AML Treatment Approaches Expand for Older and High-Risk Patients

February 1, 2023

What Promising AML Treatments Are Available for Newly Diagnosed Patients?

February 1, 2023

Long-Term Effects Acute Myeloid Leukemia Patients Should Know

February 1, 2023

What Are Some Clinical Predictors for Relapse in Acute Myeloid Leukemia?

February 1, 2023

What Does Transfusion Burden Mean in Acute Myeloid Leukemia?

February 1, 2023

Assessing Untreated AML Patients Who Are Ineligible for Intensive Chemotherapy

February 1, 2023

What AML Treatment Options Are Available for MRD-Positive Patients?

February 1, 2023

What Is MRD-Positive Acute Myeloid Leukemia?

February 1, 2023

What Is FLT3-Mutated Acute Myeloid Leukemia?

February 1, 2023

What Are the Latest Acute Myeloid Leukemia Therapies?

January 31, 2023

What Are the Latest Acute Myeloid Leukemia Therapies?

January 31, 2023

AML Clinical Trials, Access, and Health Disparities

Novel AML Therapy Use | Impact of Socioeconomic Status and Other Factors

May 24, 2024

Underrepresented AML Clinical Trial Groups | What Solutions Are Underway?

May 24, 2024

Why Is Post-Access Enrollment Vital in AML Clinical Trial Participation?

May 24, 2024

What AML Clinical Trial Inequities Do Minority and Ethnic Groups Face?

May 24, 2024

What Are Key Acute Myeloid Leukemia Care Barriers and Solutions?

May 24, 2024

Advancing Equity | Research Initiatives in AML Disparities Among Black and Latinx Populations

March 25, 2024

AML Diagnosis Disparities | Factors Impacting Underrepresented Racial and Ethnic Groups

March 25, 2024

How Do AML Patients and Outcomes Differ by Population Groups?

March 25, 2024

Black and Latinx AML Patients | The Impact of Cultural Beliefs

March 25, 2024

AML Clinical Trial Participation Disparities | Impact on Access, Outcomes, and Inclusion Strategies

March 24, 2024

BIPOC Patients Living With AML | Mortality Rate and Favorable Genetics

February 1, 2023

AML Clinical Trials Critical to Treatment Breakthroughs and Improvements

February 1, 2023

What Different AML Subtypes Are More Prevalent in Certain Demographics?

February 1, 2023

How Can We Address Disparities in AML Among Diverse Populations?

February 1, 2023

Bone Marrow Biopsies & Predictors of AML Outcomes

What Is the Role of Bone Marrow Biopsies in AML Treatment?

May 24, 2024

Do AML Bone Marrow Biopsies Show Racial and Ethnic Variances?

May 24, 2024

How Bone Marrow Biopsies Impact Acute Myeloid Leukemia Treatment and Care

May 24, 2024

How Can Bone Marrow Biopsies Be Used in AML Care?

March 25, 2024

How Is AML Care Impacted by Bone Marrow Biopsy Results?

March 24, 2024

AML Diagnosis | Exploring Bone Marrow Biopsy and Alternatives

March 24, 2024

Patient-Centered Care & Treatment Decisions

Why Is Shared Decision-Making Important for AML Patients?

May 24, 2024

Do AML Patients Receive Allo or Auto Stem Cell Transplant?

March 25, 2024

How Can AML Patients Benefit From Shared Decision-Making?

March 25, 2024

The Importance of Acute Myeloid Leukemia Patient Empowerment

March 16, 2023

[ACT]IVATED AML Resources

[ACT]IVATED AML Patient Plan

June 4, 2024

[ACT]IVATED AML North American Specialist Treatment Centers

June 4, 2024

[ACT]IVATED AML Toolkit Checklist

June 4, 2024

Informed and [ACT]IVATED Decision-Making in Acute Myeloid Leukemia Care

June 1, 2024

[ACT]IVATED AML Resource Guide III en español

May 29, 2024

[ACT]IVATED AML Resource Guide III

May 29, 2024

[ACT]IVATED AML Resource Guide II

April 22, 2024

[ACT]IVATED AML Resource Guide II en español

April 22, 2024

Becoming an Empowered and [ACT]IVATED AML Patient

March 14, 2023

[ACT]IVATED AML Resource Guide en español

March 1, 2023

[ACT]IVATED AML Resource Guide

January 31, 2023

Staying [ACT]IVATED AML Guide

How Does Health Policy Impact Me? Activity Guide

AML Activity Guide

How Does Health Policy Impact Me?

AML Patient Self-Advocacy Profiles

A Patient’s Proactive Path to an Acute Myeloid Leukemia Diagnosis

June 20, 2024

Un superviviente de 30 años de leucemia mieloide aguda comparte su experiencia

March 14, 2023

30-Year Acute Myeloid Leukemia Survivor Shares His Journey

March 14, 2023

Advocacy Tips From an AML Patient

March 13, 2023

How I Overcame Biases During AML Treatment

March 13, 2023

What I Wish I Knew Before My AML Diagnosis

March 13, 2023

How Does One’s Culture Impact AML Care?

March 13, 2023

Cómo la resiliencia de una sobreviviente de AML le salvó la vida

March 1, 2023

[ACT]IVATED AML is brought to you by Patient Empowerment Network. Funding is provided by an unrestricted educational grant from AbbVie, Inc., Merck and through generous donations from people like you.